SYMPOSIA
SYMPOSIA
SYMPOSIA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Female adolescents S125<br />
Female reproductive hormones S193<br />
Fish oil S135<br />
Flight safety S103<br />
Fluanxol S129<br />
Fluoxetine S113, S130, S147, S179, S194<br />
FMRI S62, S108, S189<br />
Foetality S171<br />
Follow-up S176<br />
Forced swimming test S166<br />
Forensic S202<br />
Forensic psychiatric examination S128<br />
Functional outcomes S136<br />
Functional remission S188<br />
Functioning S86<br />
GABA S51<br />
Galactorrhea S147, S160<br />
Ganser Syndrome S159<br />
Gating S49<br />
Gender S140<br />
Generalized anxiety disorder S193<br />
Generalized convulsion S118<br />
Genes S52<br />
Genetic S68S 100<br />
Genetic association S46<br />
Genetic polymorphism S131, S132<br />
Genomic diagnostics S157<br />
GFAP S169<br />
Ginseng augmentation therapy S114<br />
Glia S50, S51<br />
Glossodynia S161<br />
Glutamate S40, S49, S50, S51, S69, S70<br />
Glutathione S169<br />
Glycine S50<br />
GOT S116<br />
GPT S116<br />
Guidelines S98, S100<br />
GWAS S157, S198<br />
Hallucination S121<br />
Haloperidol S129<br />
Happiness S34<br />
Harm minimization S42<br />
Health S34<br />
Hematological S130<br />
Heroin S109<br />
Hippocampal neurogenesis S91<br />
HIV/AIDS S42<br />
HLA-system S46<br />
Hoarding S134<br />
Homework assignments S41<br />
HPA axis S51<br />
Human characteristics S34<br />
Human cognition S108, S189<br />
Huntington’s disease S152<br />
Hyperammonemic encephalopathy S164<br />
Hyperprolactinemia S124, S135, S160<br />
Hypersexual disorders S52<br />
Hypersomnia S44<br />
Hypochondriasis S105<br />
Hypoglycemia S78<br />
Hypomania S194<br />
Hyponatremia S139, S141<br />
Hypothalamic-pituitary-thyroid axis S77<br />
ICAM-1 S143<br />
Imipramine S185<br />
Immunosuppresive treatment S161<br />
Impulse control disorder S53<br />
Impulsivity S94<br />
In vitro analysis S115<br />
Inappropriate medications S168<br />
Individualized medicine S101<br />
Inflammation S184<br />
Information processing disorder S49<br />
Inpatient S191<br />
Insight 188<br />
Insomnia S139<br />
Insulin S78<br />
Insulin resistance S78<br />
Interethnic differences S131<br />
Iron deficiency S74<br />
Isolated thrombocytopenia S190<br />
Ketamine S49, S69<br />
Lack of self confidence S111<br />
Lactation S48, S71, S71<br />
Lamotrigine S142<br />
Lateral ventricle S61<br />
Learning S112<br />
Leukopenia S127<br />
Lipid peroxidation S140<br />
Lithium S169<br />
Lithium carbonate S161<br />
Locomotor activity S141<br />
Long QTc S119<br />
Losartan S132<br />
Lung functions 141<br />
Magnetic resonance imaging S61<br />
Maintenance S176<br />
Maintenance phase S100<br />
Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org<br />
Subject Index<br />
Major depressive disorder S115<br />
Male patient S195<br />
Malondialdehyde S169<br />
Management S95<br />
Mania S157, S194<br />
Manic episode S124<br />
Marital conflict S144, S184<br />
Mechanism of action S63<br />
Medical care S156<br />
Medical decision support systems S157<br />
Medical diseases S67<br />
Medical marijuana S37<br />
Medication S40, S43<br />
Mega cisterna magna S195<br />
Melatonin S75<br />
Mental diseases S200<br />
Mental disorder S144, S184<br />
Mental health S154<br />
Mental illness S196<br />
Mental symptom S123, S135<br />
Mentalizing S56<br />
Metabolic syndrome S180<br />
Metabolic S171<br />
Metabolic side effect S140<br />
Methadone S35, S114<br />
Methadone substitution therapy S137<br />
Methylphenidate S139, S190<br />
Metoprolol S119<br />
METU-SNP S102, S157<br />
MGLU receptors S70<br />
Middle-aged male S139<br />
Mindfulness S40, S105<br />
Mirtazapine S139, S175, S190, S196<br />
Mixed mania S98<br />
Modafinil S44<br />
Models S49<br />
Molecular diagnostics S102<br />
Mood S89, S91, S153<br />
Mood disorder S77, S79, S134, S149, S162<br />
Mood stabiliser S149<br />
MRI S62<br />
Music therapy S191<br />
Myeloperoxidase S46, S169<br />
NADPH-oxidase S46<br />
Neuroactive steroids S50, S51<br />
Neurocognitive functions S193<br />
Neurodegeneration S90, S91<br />
Neurodevelopment S49<br />
Neurodevelopmental disorders S75<br />
Neurogenesis S193<br />
Neuroimaging S36, S62, S148<br />
Neuroleptic malignant syndrome S125<br />
Neurological S201<br />
Neurological co-morbidity, treatment S97<br />
Neurological deficits S164<br />
Neuromodulation S117<br />
Neuropathic pain S59<br />
Neuroplasticity S90<br />
Neuroprotection S112<br />
Neuroprotective effect S90<br />
Neuroregeneration S91<br />
Neurotrophic factors S70<br />
Neutropenia S127<br />
Nicotine S112<br />
Nitric oxide S50<br />
NMDA S40, S70<br />
NMDA receptor S49, S69<br />
Non-seasonal affective disorder S89<br />
Normal pressure hydrocephalus S169<br />
Nutraceuticals S108, S153, S189<br />
Nymphomania S52<br />
Obesity S94<br />
Obsessive beliefs S137<br />
Obsessive compulsive behavior S126<br />
Obsessive compulsive disorder S71, S134, S176, S177<br />
Obsessive compulsive spectrum S182<br />
Obstructive sleep apnea S200<br />
Occupation S58<br />
OCD S59, S137, S172<br />
Olanzapine S171, S180, S190<br />
Olfaction S193<br />
Oman S145<br />
Omega fatty acids S75<br />
Omega-3 fatty acids S64<br />
Ontogenesis S171<br />
Opioid dependence S35<br />
Opioid withdrawal syndrome S114<br />
Orally disintegrating olanzapine S115<br />
Outpatient forensic psychiatric examination S181<br />
Oxford S202<br />
Oxidative stress S170, S189<br />
Oxytocin S76, S133, S118<br />
P value S104<br />
Pain S54, S55, S81, S82<br />
Pain reflex 141<br />
Pain threshold S178<br />
Paliperidone S165<br />
Panic disorder S78, S106, S122, S137, S189, S71